Payment overview · 2025
General Payments
$172.31
2 reported records · 2 companies
Healthcare provider profile · identity verified
Daniel E Harvey, MD
Allopathic & Osteopathic Physicians|Family Medicine · CARSON, CA · NPI 1194759688
Verified facts
What the public records show
CMS Open Payments records show Daniel E Harvey, MD received $172.31 in general payments during 2025 across 2 reported records.
Stryker Corporation accounted for 91.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $158.33 | 91.9% | 1 | 2025 |
| Supernus Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $13.98 | 8.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $172.31 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| UNIVERSAL NEURO 3 Normalized: universal neuro 3 |
Device | Stryker Corporation | $158.33 | 1 | 2025 |
Source payment records
|
|||||
| Qelbree Normalized: qelbree |
Drug | Supernus Pharmaceuticals, Inc. | $13.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 790 | 236 |
| Amlodipine Besylate | Amlodipine Besylate | 762 | 218 |
| Omeprazole | Omeprazole | 385 | 122 |
| Metformin Hcl | Metformin Hcl | 382 | 107 |
| Lisinopril | Lisinopril | 336 | 90 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 310 | 109 |
| Azithromycin | Azithromycin | 303 | 197 |
| Losartan Potassium | Losartan Potassium | 274 | 82 |
| Hydrochlorothiazide | Hydrochlorothiazide | 243 | 79 |
| Diclofenac Sodium | Diclofenac Sodium | 229 | 65 |
| Gabapentin | Gabapentin | 224 | 67 |
| Ozempic | Semaglutide | 210 | 50 |
| Furosemide | Furosemide | 204 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 202 | 61 |
| Trazodone Hcl | Trazodone Hcl | 198 | 50 |
| Levothyroxine Sodium | Levothyroxine Sodium | 189 | 45 |
| Alendronate Sodium | Alendronate Sodium | 175 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 169 | 48 |
| Levofloxacin | Levofloxacin | 149 | 105 |
| Metoprolol Succinate | Metoprolol Succinate | 145 | 40 |
| Simvastatin | Simvastatin | 142 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 141 | 29 |
| Methylprednisolone | Methylprednisolone | 139 | 78 |
| Carvedilol | Carvedilol | 135 | 32 |
| Eliquis | Apixaban | 133 | 31 |
| Ibuprofen | Ibuprofen | 121 | 38 |
| Atenolol | Atenolol | 120 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 116 | 33 |
| Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | 114 | 90 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 111 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 110 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 105 | 28 |
| Glipizide | Glipizide | 92 | 24 |
| Famotidine | Famotidine | 90 | 24 |
| Prednisone | Prednisone | 90 | 37 |
| Jardiance | Empagliflozin | 82 | 15 |
| Farxiga | Dapagliflozin Propanediol | 78 | 24 |
| Potassium Chloride | Potassium Chloride | 77 | 19 |
| Levetiracetam | Levetiracetam | 76 | 16 |
| Benazepril Hcl | Benazepril Hcl | 75 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 26 |
| Mounjaro | Tirzepatide | 69 | 13 |
| Clonidine Hcl | Clonidine Hcl | 68 | 21 |
| Januvia | Sitagliptin Phosphate | 68 | 18 |
| Xarelto | Rivaroxaban | 67 | 18 |
| Allopurinol | Allopurinol | 66 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | 12 |
| Ketoconazole | Ketoconazole | 62 | 46 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 60 | 20 |
| Nifedipine Er | Nifedipine | 59 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 57 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 57 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 54 | 30 |
| Sertraline Hcl | Sertraline Hcl | 53 | 14 |
| Linzess | Linaclotide | 52 | 15 |
| Ondansetron Odt | Ondansetron | 51 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 51 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 50 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 31 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 47 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | suppressed |
| Mupirocin | Mupirocin | 44 | 21 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 44 | 18 |
| Baclofen | Baclofen | 41 | suppressed |
| Cefdinir | Cefdinir | 41 | 33 |
| Fluconazole | Fluconazole | 41 | 21 |
| Lidocaine | Lidocaine | 40 | 16 |
| Acyclovir | Acyclovir | 38 | 14 |
| Finasteride | Finasteride | 38 | 14 |
| Kerendia | Finerenone | 38 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 38 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 37 | 21 |
| Sodium Chloride | 0.9 % Sodium Chloride | 37 | suppressed |
| Celecoxib | Celecoxib | 35 | suppressed |
| Latanoprost | Latanoprost | 35 | suppressed |
| Colchicine | Colchicine | 34 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | suppressed |
| Mirtazapine | Mirtazapine | 32 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 15 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 30 | 15 |
| Sildenafil Citrate | Sildenafil Citrate | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 22 |
| Buspirone Hcl | Buspirone Hcl | 29 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Spironolactone | Spironolactone | 29 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Alprazolam | Alprazolam | 28 | suppressed |
| Sucralfate | Sucralfate | 28 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 27 | 20 |
| Vraylar | Cariprazine Hcl | 27 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 25 | suppressed |
| Ertapenem | Ertapenem Sodium | 25 | suppressed |
| Memantine Hcl | Memantine Hcl | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 24 | 13 |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 16 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Loperamide | Loperamide Hcl | 23 | 14 |
| Divalproex Sodium | Divalproex Sodium | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 11 |
| Hydrocortisone | Hydrocortisone | 22 | 11 |
| Memantine Hcl Er | Memantine Hcl | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 20 |
| Ramipril | Ramipril | 21 | suppressed |
| Tradjenta | Linagliptin | 21 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Ivermectin | Ivermectin | 20 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 19 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Erythromycin | Erythromycin Base | 19 | suppressed |
| Olanzapine | Olanzapine | 19 | suppressed |
| Ssd | Silver Sulfadiazine | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Metolazone | Metolazone | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Auryxia | Ferric Citrate | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Permethrin | Permethrin | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Klor-Con 10 | Potassium Chloride | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | 11 |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 14 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 14 | suppressed |
| Procto-Med Hc | Hydrocortisone | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Spinosad | Spinosad | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Risedronate Sodium Dr | Risedronate Sodium | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $172.31 · 2 records | Stryker Corporation | Qelbree, UNIVERSAL NEURO 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error